Mesothelioma is a type of cancer that mainly affects the lining of the lungs and the chest wall, caused by exposure to asbestos. When we talk about life expectancy, ... Read more
Elevated platelet levels in malignant peritoneal mesothelioma (MPM) patients being considered for surgery is associated with poor outcomes, a cohort study shows. The study, “Preoperative Thrombocytosis Predicts Shortened Survival in ... Read more
Mesothelioma patients treated with chemotherapy and a modern type of radiotherapy called IMPRINT survive longer after lung-sparing surgery than patients who received conventional radiotherapy, an analysis of patient outcomes ... Read more
Mesothelioma Research News interviewed Angelos Stergiou, MD, ScD, CEO and vice chairman of the board, and Nicholas Sarlis, MD, PhD, senior vice president and chief medical officer of Sellas ... Read more
Bermuda-based Sellas Life Sciences Group will conduct a Phase 3 clinical trial to investigate the efficacy and safety of the galinpepimut-S vaccine as a potential treatment for patients with malignant ... Read more
Measures of progression-free survival cannot be used as substitute measures for overall survival in clinical trials of malignant mesothelioma, according to an analysis of data from 17 trials. The ... Read more
Quantitative 18F-FDG positron emission tomography/computed tomography (PET/CT) parameters based on pre-treatment tumor volume could be used as surrogate markers to predict the expected course of malignant pleural mesothelioma and ... Read more
Postoperative radiotherapy has limited survival benefits for certain patients with malignant pleural mesothelioma (MPM) who have had surgery to remove the cancer, researchers said in a recent retrospective study, and they ... Read more
Surgery improves overall survival in patients with malignant pleural mesothelioma, even among elderly patients, according to the results of the study, “Impact of Age on Long-Term Outcomes of Surgery for ... Read more
Chinese researchers reported that levels of CA125 — a serum marker used to monitor certain cancers — could aid in predicting overall survival and chemotherapy response in people with diffuse malignant mesothelioma. ... Read more
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more
